OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Barriers to immune cell infiltration in tumors
Marit M. Melssen, Natasha D. Sheybani, Katie M. Leick, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 4, pp. e006401-e006401
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Precision treatment in advanced hepatocellular carcinoma
Xupeng Yang, Chen Yang, Shu Zhang, et al.
Cancer Cell (2024) Vol. 42, Iss. 2, pp. 180-197
Open Access | Times Cited: 124

Endothelin-1 in Health and Disease
Katherine M. R. M. Banecki, Kim A. Dora
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11295-11295
Open Access | Times Cited: 44

How to build the virtual cell with artificial intelligence: Priorities and opportunities
Charlotte Bunne, Yusuf Roohani, Yanay Rosen, et al.
Cell (2024) Vol. 187, Iss. 25, pp. 7045-7063
Open Access | Times Cited: 16

Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing
Alice Perucca, Andrea Gómez Llonín, Oriol Mañé Benach, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2

Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies
Siwei Zheng, Wenwen Wang, Lesang Shen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 14

Lactylation modulation identifies key biomarkers and therapeutic targets in KMT2A-rearranged AML
Dan Liu, Silu Liu, Yujie Ji, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1

Clinico‐Pathological Significance of Tumor Infiltrating Immune Cells in Oral Squamous Cell Carcinoma—Hope or Hype?
Rajkumar Kottayasamy Seenivasagam, Ashok Singh, Vinay N. Gowda, et al.
Head & Neck (2025)
Open Access | Times Cited: 1

Coengineering specificity, safety, and function into T cells for cancer immunotherapy
Greta Maria Paola Giordano Attianese, Sarah Ash, Melita Irving
Immunological Reviews (2023) Vol. 320, Iss. 1, pp. 166-198
Open Access | Times Cited: 17

CAR-T therapy and targeted treatments: Emerging combination strategies in solid tumors
Jiahao Liu, Xiaofei Jiao, Ding Ma, et al.
Med (2024) Vol. 5, Iss. 6, pp. 530-549
Closed Access | Times Cited: 7

The Tumor Stroma of Squamous Cell Carcinoma: A Complex Environment That Fuels Cancer Progression
Alexandra Buruiană, Bogdan‐Alexandru Gheban, Ioana‐Andreea Gheban‐Roșca, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1727-1727
Open Access | Times Cited: 7

Engineered bacteria breach tumor physical barriers to enhance radio-immunotherapy
Yanxiang Zhang, Yue Liu, Tingting Li, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 867-878
Closed Access | Times Cited: 7

Tumor-associated fibrosis: a unique mechanism promoting ovarian cancer metastasis and peritoneal dissemination
Hiroki Fujimoto, Masato Yoshihara, Raymond J. Rodgers, et al.
Cancer and Metastasis Reviews (2024)
Open Access | Times Cited: 6

Glucose oxidase and metal catalysts combined tumor synergistic therapy: mechanism, advance and nanodelivery system
Yuhan Fu, Jialin Sun, Yanhong Wang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13

Beyond Small Molecules: Antibodies and Peptides for Fibroblast Activation Protein Targeting Radiopharmaceuticals
Xiaona Sun, Yuxuan Wu, Xingkai Wang, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 345-345
Open Access | Times Cited: 5

A nanodrug provokes antitumor immune responses via synchronous multicellular regulation for enhanced cancer immunotherapy
Keze Hong, Jianrong Cao, Weiting Jiang, et al.
Journal of Colloid and Interface Science (2024) Vol. 678, pp. 750-762
Closed Access | Times Cited: 5

Overcoming Resistance to Immune Checkpoint Blockade in Liver Cancer with Combination Therapy: Stronger Together?
Wiebke Werner, Maria Kuzminskaya, Isabella Lurje, et al.
Seminars in Liver Disease (2024) Vol. 44, Iss. 02, pp. 159-179
Open Access | Times Cited: 4

Recent advances in understanding the immune microenvironment in ovarian cancer
Jinxin Chen, Lu Yang, Yiming Ma, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4

Transcriptomic analysis of the immune response to in vivo gene electrotransfer in colorectal cancer
Mariangela De Robertis, Tim Božič, Iva Šantek, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 1, pp. 102448-102448
Open Access

Tumor cells escape immunosurveillance by hampering LFA-1
Shishir Upadhyay, Lewis Murugu, Lena Svensson
Frontiers in Immunology (2025) Vol. 16
Open Access

From conventional to cutting edge: an exploration of osteosarcoma treatments
G. J. Sellers, Martin Poirier, Trenton G Mayberry, et al.
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access

Development of attenuated Orf virus as a safe oncolytic viral vector for nasopharyngeal carcinoma treatment
Yumiko Yamada, Yu‐Chih Wang, Hao‐Ping Liu, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access

The prognostic impact of PBRM1 immunohistochemical expression and its association with CD3+ and CD8+ immune cells in patients with renal cell carcinoma: A retrospective study
Amira Emad Elwy, Mahmoud Nassar, Shimaa Hassan Shaban, et al.
Pathology - Research and Practice (2025) Vol. 268, pp. 155863-155863
Closed Access

Stromal Fibrin Shapes Immune Infiltration Landscape of Pancreatic Ductal Adenocarcinoma
Mazharul Karim, Md. Mahedi Hasan, Seung Hyun Kim, et al.
Biomaterials (2025), pp. 123280-123280
Closed Access

Page 1 - Next Page

Scroll to top